The Effects of a Disease Management Program on Self-Reported Health Behaviors and Health Outcomes: Evidence From the “Florida: A Healthy State (FAHS)” Medicaid Program

Premature morbidity and mortality from chronic diseases account for a major proportion of expenditures for health care cost in the United States. The purpose of this study was to measure the effects of a disease management program on physiological and behavioral health indicators for Medicaid patients in Florida. A two-year prospective study of 15,275 patients with one or more chronic illnesses (congestive heart failure, hypertension, diabetes, or asthma) was undertaken. Control of hypertension improved from baseline to Year 1 (adjusted odds ratio = 1.60, p < .05), with maintenance at Year 2. Adjusted cholesterol declined by 6.41 mg/dl from baseline to Year 1 and by 12.41 mg/dl ( p < .01) from baseline to Year 2. Adjusted average medication compliance increased by 0.19 points ( p < .01) in Year 1 and 0.29 points ( p < .01) in Year 2. Patients in the disease management program benefited in terms of controlling hypertension, asthma symptoms, and cholesterol and blood glucose levels.

Download Full-text

Efficacy and Outcomes of a Novel Telephone-based Gout Disease Management Program

The Open Rheumatology Journal ◽

10.2174/1874312902115010051 ◽

2021 ◽

Vol 15 (1) ◽

pp. 51-56

Author(s):

Abdalhamid Al Harash ◽

Gina Laginya ◽

William T. Ayoub

Keyword(s):

Patient Satisfaction ◽

Disease Management ◽

Disease Management Program ◽

Care Center ◽

The United States ◽

Likert Scale ◽

Management Program ◽

Cost Of Care ◽

Urgent Care ◽

Urgent Care Center

Objective: Gout is the most common inflammatory arthritis in the United States. Despite published guidelines, management remains suboptimal, leading to unnecessary morbidity and increased cost of care. We have designed the gout disease management program (GDMP) to improve outcomes, increase patient satisfaction, and decrease healthcare utilization. Methods: Gout patients were seen at their usual rheumatology clinical visit and offered participation in the GDMP. Data were collected between April 2017 and November 2019. Serum uric acid (SUA) levels were measured at the initial outpatient encounter, at the entrance to GDMP, and every 4 weeks until SUA was at the goal of ≤6 mg/dl. Through telephonic encounters, gout-related recent hospitalizations, and ER or urgent care visits since the last encounter were ascertained. Self-reported gout medication usage and adherence were also determined. Patient satisfaction with GDMP was surveyed using a 5-point Likert scale. Results: A total of 158 patients were enrolled, of which 112 had ≥ 1 telephone encounter and were included in our analyses. During the telephone phase, 79 patients (70%) achieved the SUA goal of ≤6.0 mg/dl. Only 3 patients (2.6%) required hospitalization or visits to an ER or urgent care center due to gout flare, and 98% rated their encounter as a 5 on the 5-point Likert scale. Conclusion: Our telephone-based management program for gout led to improved clinical outcomes as defined by the ACR guidelines, decreased healthcare visits, and had high patient satisfaction. Significance and Innovations: • First telephone-based, rheumatology providers-led study to manage gout • Additional evidence to confirm the feasibility and benefit of telemedicine in common diseases • First study to show excellent patient satisfaction

Download Full-text

Efficacy and Outcomes of a Novel Telephone-based Gout Disease Management Program

10.21203/rs.3.rs-36000/v1 ◽

2020 ◽

Author(s):

Abdalhamid Al Harash ◽

Tarun Sharma ◽

Gina Laginya ◽

Mary Chester M Wasko ◽

William T Ayoub

Keyword(s):

Patient Satisfaction ◽

Disease Management ◽

Disease Management Program ◽

Care Center ◽

The United States ◽

Likert Scale ◽

Management Program ◽

Cost Of Care ◽

Urgent Care ◽

Urgent Care Center

Abstract Objective: Gout is the most common inflammatory arthritis in the United States. Despite published guidelines, management remains suboptimal, leading to unnecessary morbidity and increased cost of care. We have designed the gout disease management program (GDMP) to improve outcomes, increase patient satisfaction and decrease healthcare utilization.Methods: Gout patients were seen at their usual rheumatology clinical visit and offered participation in the GDMP. Data were collected between April 2017 and May 2019. Serum uric acid (SUA) levels were measured at initial outpatient encounter, at entrance to GDMP and every 4 weeks until SUA was at goal of ≤6 mg/dl. During telephone encounters, gout-related recent hospitalizations and ER or urgent care visits since last encounter were ascertained. Self-reported gout medication usage and adherence were also determined. Patient satisfaction with GDMP was surveyed using a 5-point Likert scale.Results: A total of 158 patients were enrolled, of which 112 had ≥ 1 telephone encounter and were included in our analyses. During the telephone phase, 79 patients (70%) achieved SUA goal of ≤6.0 mg/dl, while90 patients (80%) achieved an acceptable SUA of ≤6.5 mg/dl. Only 3 patients (2.6%) required hospitalization or visits to an ER or urgent care center due to gout flare, and 98% rated their encounter as a 5 on the 5-point Likert scale.Conclusion: Our telephone-based management program for gout led to improved clinical outcomes as defined by the ACR guidelines, decreased healthcare visits, and had high patient satisfaction.

Download Full-text

225 Anaemia in a heart failure disease management program: iron deficiency or anaemia of chronic disease

European Journal of Heart Failure Supplements ◽

10.1016/s1567-4215(03)90147-0 ◽

2003 ◽

Vol 2 (1) ◽

pp. 48

Author(s):

E RYAN ◽

M LEDWIDGE ◽

K MCDONALD

Keyword(s):

Heart Failure ◽

Chronic Disease ◽

Iron Deficiency ◽

Disease Management ◽

Disease Management Program ◽

Management Program ◽

Anaemia Of Chronic Disease ◽

Heart Failure Disease Management

Download Full-text

Transition im Disease Management Program (DMP) – Altersspezische Unterschiede am Beispiel der medikamentösen Versorgung der Teilnehmer am DMP Asthma bronchiale in der Region Nordrhein

Pneumologie ◽

10.1055/s-0034-1367881 ◽

2014 ◽

Vol 68 (S 01) ◽

Author(s):

A Weber ◽

S Groos ◽

B Hagen ◽

J Kretschmann ◽

L Altenhofen

Keyword(s):

Disease Management ◽

Disease Management Program ◽

Asthma Bronchiale ◽

Management Program

Download Full-text

Two Exercise Programs for People with Diabetes and Visual Impairment

Journal of Visual Impairment & Blindness ◽

10.1177/0145482x9308700916 ◽

1993 ◽

Vol 87 (9) ◽

pp. 365-367

Author(s):

J. Dods

Keyword(s):

United States ◽

Blood Glucose ◽

Visual Impairment ◽

The United States ◽

Exercise Programs ◽

Daily Lives ◽

Glucose Levels ◽

Basic Model ◽

Blood Glucose Levels ◽

Exercise Regimen

This article describes two programs—one in Australia and one in the United States—that teach people with diabetes and visual impairment to incorporate proper diets and exercise into their daily lives and hence to gain better control of their blood glucose levels. It also presents a basic model of an exercise regimen that clients can perform at home.

Download Full-text